Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

Otsuka

Status and phase: Completed; Phase 3; Phase 2

Conditions: Schizophrenia

Treatments: Drug: aripiprazole

Study type: Interventional

Funder types: Industry

Identifiers

NCT00036127

CN138-050

Details and patient eligibility

About

Study to learn if the alternate formulation is effective in agitated schizophrenic patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Agitated schizophrenic patients